VBI research offers potential route to diabetes therapeutics

Armen Hareyan's picture
Advertisement

Work in the laboratory of Virginia Bioinformatics Institute (VBI) Assistant Professor Biswarup Mukhopadhyay is providing important information for researchers designing drugs for type 2 diabetics.

Advertisement

The research, which was published in the December 22, 2006, Journal of Biological Chemistry, should in time help researchers to identify potential targets for docking inhibitors that will slow down, but not fully eliminate, the body's overproduction of glucose.

The study investigates ways to control the activity of phosphoenolpyruvate carboxykinase

Advertisement